| Jul 30 |
Repligen Non-GAAP EPS of $0.33 in-line, revenue of $154M in-line; updates FY24 outlook
|
| Jul 30 |
Repligen Reports Second Quarter 2024 Financial Results
|
| Jul 30 |
Should You Consider Investing in Repligen Corporation (RGEN)?
|
| Jul 29 |
Repligen acquiring Tantti Laboratory to boost chromatography applications
|
| Jul 29 |
Repligen to acquire Tantti Laboratory of Taoyuan City, Taiwan
|
| Jul 29 |
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
|
| Jul 29 |
Repligen Q2 2024 Earnings Preview
|
| Jul 24 |
Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Jul 23 |
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
|
| Jul 20 |
Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now?
|
